PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
94.45
+1.75 (1.89%)
Nov 21, 2024, 4:00 PM EST - Market closed
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for PROCEPT BioRobotics stock have an average target of 89.5, with a low estimate of 69 and a high estimate of 105. The average target predicts a decrease of -5.24% from the current stock price of 94.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRCT stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 4 | 3 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 6 | 6 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Initiates $95 | Hold | Initiates | $95 | +0.58% | Nov 14, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $95 → $105 | Strong Buy | Reiterates | $95 → $105 | +11.17% | Oct 30, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $75 | Buy | Reiterates | $75 | -20.59% | Oct 8, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $75 → $99 | Strong Buy | Maintains | $75 → $99 | +4.82% | Sep 16, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $74 → $95 | Strong Buy | Maintains | $74 → $95 | +0.58% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
227.52M
from 136.19M
Increased by 67.06%
Revenue Next Year
319.87M
from 227.52M
Increased by 40.59%
EPS This Year
-1.77
from -2.24
EPS Next Year
-1.36
from -1.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 235.1M | 340.2M | 457.8M | ||
| Avg | 227.5M | 319.9M | 422.1M | ||
| Low | 218.1M | 289.0M | 355.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 72.6% | 49.5% | 43.1% | ||
| Avg | 67.1% | 40.6% | 32.0% | ||
| Low | 60.2% | 27.0% | 11.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.82 | -1.28 | -0.60 | ||
| Avg | -1.77 | -1.36 | -0.80 | ||
| Low | -1.72 | -1.49 | -1.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.